Sinclair Research’s Response
to COVID-19 Pandemic
Sinclair Research, a leading provider of nonclinical contract research services, today announced the successful GLP validation of its Safety Pharmacology services in partnership with CorDynamics, a premier provider of cardiovascular toxicology and safety pharmacology...
Sinclair Research, a leading provider of nonclinical research services, has named Dr. Tina Rogers, PhD, MBA, DABT as Senior Scientific Advisor.
Sinclair Research announces strategic partnership with Bolder BioPATH to expand early-stage discovery model portfolio
Auxvasse, Mo. -- Sinclair Research, a leading provider of nonclinical contract research services, today announced a strategic partnership with Bolder BioPATH, a premier provider of pharmacology and pathology services specializing in in vivo models of Rheumatoid...
Sinclair Research announced the completion of successful validation of GLP ototoxicity testing services in partnership with Turner Scientific.
Sinclair Research recently expanded its GLP nonclinical toxicology facility by adding additional research space dedicated to support nonclinical toxicology research. The new expansion increases our room capacity by more than 25 percent, allowing Sinclair to continue...